Maternal serum -HCG and -fetoprotein concentrations in singleton pregnancies following assisted reproduction
Open Access
- 1 March 2002
- journal article
- research article
- Published by Oxford University Press (OUP) in Human Reproduction
- Vol. 17 (3) , 794-797
- https://doi.org/10.1093/humrep/17.3.794
Abstract
BACKGROUND: The reason for the elevated levels of HCG in assisted reproduction pregnancies remains unknown. Our hypothesis was that this increase is caused by the ovarian superovulation therapy. METHODS: We compared the β-HCG and α-fetoprotein (AFP) multiples of the median (MoM) in singleton pregnancies after IVF or ICSI with those achieved by frozen embryo transfer (FET) in spontaneous cycles. RESULTS: The HCG and AFP MoMs (± SEMs) of 59 FET pregnancies were compared with 144 IVF (including 48 ICSI) pregnancies. The maternal HCG of pregnancies following ovarian stimulation was 1.31 ± 0.08 MoM compared with 1.35 ± 0.12 MoM in the unstimulated ones. The values for AFP were 1.06 ± 0.05 versus 1.11 ± 0.05 respectively. No significant differences could be observed between pregnancies following stimulated IVF/ICSI and unstimulated FET cycles. CONCLUSIONS: Our results show that second trimester maternal serum HCG is also elevated in singleton pregnancies following spontaneous FET cycles. The increased maternal serum HCG in IVF pregnancies is thus not related to superovulation therapy. Because of the elevated maternal serum HCG levels, serum screening cannot be performed reliably in pregnancies following assisted reproduction technology. Ultrasonographic detection of the nuchal translucency is unaffected and should be used for this group of women undergoing assisted reproduction.Keywords
This publication has 22 references indexed in Scilit:
- Human chorionic gonadotropin levels in successful implantations after assisted reproduction techniques.Gynecological Endocrinology, 2000
- Maternal serum screening for Down syndrome in pregnancies conceived by intra-uterine inseminationPrenatal Diagnosis, 1999
- Maternal serum alpha-fetoprotein and human chorionic gonadotrophin in pregnancies conceived after intracytoplasmic sperm injection and conventional in-vitro fertilizationHuman Reproduction, 1999
- Serum triple-marker screening in in vitro fertilization and naturally conceived pregnanciesObstetrics & Gynecology, 1997
- MATERNAL SERUM TESTING FOR ALPHA-FETOPROTEIN AND HUMAN CHORIONIC GONADOTROPIN IN HIGH-RISK PREGNANCIESPrenatal Diagnosis, 1996
- DOWN'S SYNDROME SCREENING MARKER LEVELS FOLLOWING ASSISTED REPRODUCTIONPrenatal Diagnosis, 1996
- Effect of in vitro fertilization on human chorionic gonadotropin serum concentrations and Down’s syndrome screeningFertility and Sterility, 1996
- Second‐trimester maternal serum screening using alpha‐fetoprotein, human chorionic gonadotrophin, and unconjugated oestriol: Experience of a regional programmePrenatal Diagnosis, 1994
- Maternal serum screening for Down's syndrome taking account of the result in a previous pregnancyPrenatal Diagnosis, 1994
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992